Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the cross-presentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hypoxic tumors have been shown to exhibit decreased MHC-I expression in tumor cells and DCs (Ramakrishnan et al., 2014).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Ramakrishnan et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 1×
“generation of cells with immune-suppressive activity, including regulatory DCs and myeloid-derived suppressor cells (4).”
BackgroundSelf-citationBatf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Lipid Droplets and Cellular Lipid Metabolism
Walther, T. C., & Farese, R. V. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061009-102430 · Cited by 1,661 · cited 1×
“The presence and size of LBs is defined by the accumulation of FA precursors and their esterification into TAGs and CEs, the major constituents of the hydrophobic core of LBs (26).”
BackgroundCross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637 · cited 2×
“The endogenous pathway of presentation invariably depends on proteasomes, whereas the pathway of cross-presentation (cytosolic or vacuolar) depends on the type of Ag and the mechanism of its uptake (12, 35).”
BackgroundMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Self-citationBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956 · cited 1×
“generate peptide T cell epitopes that are presented by MHC class I (MHC-I) molecules (9, 10).”
BackgroundLipid accumulation and dendritic cell dysfunction in cancer
Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lennox, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 735
Self-citationEndoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J. M., & Desjardins, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00797-3 · Cited by 683 · cited 1×
“In addition to recycling MHC-I, transport of MHC-I, from ER to the endocytic compartment, has also been demonstrated (49, 50).”
BackgroundMechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493 · cited 1×
“KVPRNQDWL, were used as responders (31).”
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Burgdorf, S., Schölz, C., Kautz, A., Tampé, R., & Kurts, C. (2008) · Nature Immunology · doi:10.1038/ni.1601 · Cited by 405 · cited 1×
“The endogenous pathway of presentation invariably depends on proteasomes, whereas the pathway of cross-presentation (cytosolic or vacuolar) depends on the type of Ag and the mechanism of its uptake (12, 35).”
BackgroundRecent advances in antigen processing and presentation
Jensen, P. E. (2007) · Nature Immunology · doi:10.1038/ni1516 · Cited by 382 · cited 1×
“of pMHC in the ER with the subsequent transport to the membrane (45), these components are not essential for the vacuolar pathway in Ag cross-presentation (46).”
BackgroundEngelhardt, J. J., Boldajipour, B., Beemiller, P., Pandurangi, P., Sorensen, C., Werb, Z., Egeblad, M., & Krummel, M. F. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.008 · Cited by 330
van Manen, H.-J., Kraan, Y. M., Roos, D., & Otto, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502746102 · Cited by 322 · cited 1×
“(42) have demonstrated the transient association of LBs with latex bead-containing phagosomes in neutrophils and macrophages.”
BackgroundIs the class A macrophage scavenger receptor (SR-A) multifunctional? — The mouse’s tale
Platt, N., & Gordon, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13903 · Cited by 316 · cited 2×
“This receptor binds various acetylated and oxidized lipids, including low-density lipoproteins (36).”
BackgroundWeatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S., & Hwang, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5390 · Cited by 312
Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection
Wakim, L. M., & Bevan, M. J. (2011) · Nature · doi:10.1038/nature09863 · Cited by 307 · cited 1×
“MHC-I complexes from contact with necrotic cells) (22, 23).”
BackgroundQuantitative and Dynamic Assessment of the Contribution of the ER to Phagosome Formation
Touret, N., Paroutis, P., Terebiznik, M., Harrison, R. E., Trombetta, S., Pypaert, M., Chow, A., Jiang, A., Shaw, J., Yip, C., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.018 · Cited by 285
Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage
Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pachéco, Y., & Lebecque, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2763 · Cited by 266
Endocytosis mechanisms and the cell biology of antigen presentation
Burgdorf, S., & Kurts, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.12.002 · Cited by 266 · cited 1×
“After uptake, exogenous Ags are internalized into phagosomes or endosomes (11, 12).”
BackgroundIs the class A macrophage scavenger receptor (SR-A) multifunctional? — The mouse’s tale
Platt, N., & Gordon, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113903 · Cited by 265
Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N., & Sher, A. (2002) · Nature Immunology · doi:10.1038/ni745 · Cited by 258
Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell Mobilization
Angeli, V., Llodrá, J., Rong, J. X., Satoh, K., Ishii, S., Shimizu, T., Fisher, E. A., & Randolph, G. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.003 · Cited by 257
Bevan, M. J. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.117.6.2233 · Cited by 254
Emerging Roles for Lipid Droplets in Immunity and Host-Pathogen Interactions
Saka, H. A., & Valdivia, R. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-153958 · Cited by 220
Lizée, G., Basha, G., Tiong, J., Julien, J.-P., Tian, M., Biron, K. E., & Jefferies, W. A. (2003) · Nature Immunology · doi:10.1038/ni989 · Cited by 209
Bougnères, L., Helft, J., Tiwari, S., Vargas, P., Chang, B. H.-J., Chan, L., Campisi, L., Lauvau, G., Hugues, S., Kumar, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.022 · Cited by 179 · cited 2×
“Recently, lipid droplets or lipid bodies (LBs) were implicated in cross-presentation via their association with endoplasmic reticulum (ER)–resident 47-kDa immune-related GTPase, Igtp (Irgm3) (24).”
Backgroundvan Mierlo, G. J. D., Boonman, Z. F. H. M., Dumortier, H. M. H., den Boer, A. T., Fransen, M. F., Nouta, J., van der Voort, E. I. H., Offringa, R., Toes, R. E. M., & Melief, C. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6753 · Cited by 171
Dendritic Cells Cross-Dressed with Peptide MHC Class I Complexes Prime CD8+ T Cells
Dolan, B. P., Gibbs, K. D., & Ostrand-Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6018 · Cited by 152 · cited 1×
“MHC-I complexes from contact with necrotic cells) (22, 23).”
BackgroundYewdall, A. W., Drutman, S. B., Jinwala, F., Bahjat, K. S., & Bhardwaj, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011144 · Cited by 151
A CD74-dependent MHC class I endolysosomal cross-presentation pathway
Basha, G., Omilusik, K., Chavez-Steenbock, A., Reinicke, A. T., Lack, N., Choi, K. B., & Jefferies, W. A. (2012) · Nature Immunology · doi:10.1038/ni.2225 · Cited by 145 · cited 1×
“In addition to recycling MHC-I, transport of MHC-I, from ER to the endocytic compartment, has also been demonstrated (49, 50).”
BackgroundYamagami, W., Susumu, N., Tanaka, H., Hirasawa, A., Banno, K., Suzuki, N., Tsuda, H., Tsukazaki, K., & Aoki, D. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31822c271f · Cited by 139
Bieghs, V., Verheyen, F., van Gorp, P. J., Hendrikx, T., Wouters, K., Lütjohann, D., Gijbels, M. J. J., Febbraio, M., Binder, C. J., Hofker, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034378 · Cited by 120 · cited 2×
“However, it is known that TAGs are not directly taken up by DCs but are synthesized inside the cells from FAs, and scavenger receptor A (CD204) binds primarily modified lipoproteins (32).”
BackgroundMethodShen, X., Li, N., Li, H., Zhang, T., Wang, F., & Li, Q. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0833-8 · Cited by 104
Shamshiev, A. T., Ampenberger, F., Ernst, B., Rohrer, L., Marsland, B. J., & Kopf, M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061737 · Cited by 104
Notch and Wingless Signaling Cooperate in Regulation of Dendritic Cell Differentiation
Zhou, J., Cheng, P., Youn, J.-I., Cotter, M. J., & Gabrilovich, D. I. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.021 · Cited by 102 · cited 5×
“Mouse DCs were generated from bone marrow (BM) progenitor by a 3-d culture with 10 ng/ml GM-CSF (28).”
MethodInfluentialSelf-citationPreynat-Seauve, O., Schuler, P., Contassot, E., Beermann, F., Huard, B., & French, L. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.61 · Cited by 94
Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation
Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S., & Bedford, P. A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1636::aid-immu1636>3.0.co;2-9 · Cited by 90
Basha, G., Lizée, G., Reinicke, A. T., Seipp, R. P., Omilusik, K. D., & Jefferies, W. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003247 · Cited by 85 · cited 1×
“somal and lysosomal compartments of DCs, where loading of peptides derived from exogenous proteins can occur (47, 48).”
BackgroundGerner, M. Y., Casey, K. A., & Mescher, M. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.155 · Cited by 77
Scavenger Receptor-A Negatively Regulates Antitumor Immunity
Wang, X.-Y., Facciponte, J., Chen, X., Subjeck, J. R., & Repasky, E. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3138 · Cited by 75 · cited 1×
“Msr1-deficient DCs showed a more effective Ag-presenting capability as compared with wild-type cells, but this was primarily linked with their more mature phenotype (37).”
BackgroundCytokine analysis as a tool to understand tumour–host interaction in ovarian cancer
Yigit, R., Figdor, C. G., Zusterzeel, P. L. M., Pots, J. M., Torensma, R., & Massuger, L. F. A. G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.026 · Cited by 62
Remily‐Wood, E. R., Liu, R. Z., Xiang, Y., Chen, Y., Thomas, C. E., Rajyaguru, N., Kaufman, L. M., Ochoa, J. E., Hazlehurst, L., Pinilla‐Ibarz, J., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000115 · Cited by 48 · cited 1×
“Liquid chromatography-multiple reaction monitoring mass spectrometry (MS) was performed, as previously described (29).”
Method山上, 亘. (2012) · Medical Entomology and Zoology · Cited by 46
Ascierto, P. A., Napolitano, M., Celentano, E., Simeone, E., Gentilcore, G., Daponte, A., Capone, M., Caracò, C., Calemma, R., Beneduce, G., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-76 · Cited by 45
‘Danger’ effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells
Zaguri, R., Verbovetski, I., Atallah, M., Trahtemberg, U., Krispin, A., Nahari, E., Leitersdorf, E., & Mevorach, D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03444.x · Cited by 43
CD8α+ DC are not the sole subset cross‐presenting cell‐associated tumor antigens from a solid tumor
McDonnell, A. M., Prosser, A., van Bruggen, I., Robinson, B. W. S., & Currie, A. J. (2010) · European Journal of Immunology · doi:10.1002/eji.200940153 · Cited by 42
Gadban, M. M. A., Smith, K. J., Soodavar, F., Piansay, C. M., Chassereau, C. N., Twal, W. O., Klein, R. L., Virella, G., Lopes-Virella, M. F., & Hammad, S. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012534 · Cited by 39 · cited 1×
“Inside DCs, oxidized lipid moiety can be directly trafficked to endosomes and localized in the lysosomal compartment (51).”
BackgroundTsuchiya, M., Kagan, V. E., Freisleben, H., Manabe, M., & Packer, L. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)34107-9 · Cited by 37 · cited 1×
“lipid peroxidation, we pretreated cells with a-tocopherol (vitamin E), which is known to partition into hydrophobic phases of lipid structures and has been shown to effectively inhibit lipid peroxidation in biomembranes and lipoproteins (34).”
MethodSelf-citationTyurin, V. A., Cao, W., Tyurina, Y. Y., Gabrilovich, D. I., & Kagan, V. E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.074 · Cited by 21 · cited 1×
“Our data demonstrated a substantial accumulation of different classes of neutral ox-lipids in DCs in TB hosts, which is consistent with the important role of CD204 in this process (43).”
ResultSelf-citation[14] Peroxidation of phosphatidylserine in mechanisms of apoptotic signaling
Tyurina, Y. Y., Tyurin, V. A., Shvedova, A. A., Fabisiak, J. P., & Kagan, V. E. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)52016-4 · Cited by 10 · cited 1×
“AMVN decomposes in lipids at a constant rate to yield carboncentered alkyl radicals, which react with molecular oxygen to generate reactive peroxyl radicals leading to lipid peroxidation (33).”
BackgroundSelf-citationMohammadyani, D., Tyurin, V. A., Amoscato, A. A., Gabrilovich, D. I., Klein‐Seetharaman, J., & Kagan, V. E. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.4416 · Cited by 1 · cited 1×
“The presence of very polar groups in these oxidized lipid species, or oxidatively truncated TAGs, causes their translocation and integration into the less hydrophobic surface area of LBs—as has been confirmed by our computational coarsegrained molecular dynamic simulations (52), where they can be further metabolized (…”
BackgroundSelf-citation
Cited by
Dendritic cells in cancer immunology and immunotherapy
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,574
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Metadata
- Authors
- Cao, W., Ramakrishnan, R., Tuyrin, V. A., Veglia, F., Condamine, T., Amoscato, A., Mohammadyani, D., Johnson, J. J., Min Zhang, L., Klein-Seetharaman, J., Celis, E., Kagan, V. E., & Gabrilovich, D. I.
- Affiliations
- Moffitt Cancer Center (US)
- University of Pittsburgh (US)
- The Wistar Institute (US)
- Molecular Core, H. Lee Moffitt Cancer Center and Research Institute , Tampa, FL 33612
- Division of Metabolic and Vascular Health, Medical School, University of Warwick , Coventry CV4 7AL,
- Corresponding author
- Gabrilovich, Dmitry I
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 192
- Issue
- 6
- Pages
- 2920-2931
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3998104
- OpenAlex
- W2149025737
- Cited by
- 302
- References
- 53
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 27 · 2023: 24 · 2022: 40 · 2021: 48 · 2020: 29 · 2019: 21 · 2018: 13 · 2017: 21 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA165065, R01CA136828, R01CA165065, P30CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- oxidized lipids, cross-presentation, dendritic cells, dendritic cell dysfunction, antitumor immunity, triglycerides, cholesterol esters, fatty acids, peptide-MHC class I complexes, tumor-derived factors, tumor immunology
- MeSH terms
- Acetylcysteine, Animals, Histocompatibility Antigens Class II, Cells, Cultured, Dendritic Cells, Flow Cytometry, Humans, Interferon-gamma, Lipids, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Ovalbumin, Oxidation-Reduction, Peptide Fragments, Histocompatibility Antigens Class I, Cysteine Proteinase Inhibitors, Culture Media, Conditioned, Antigen Presentation, Microscopy, Confocal, Cross-Priming, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.